• 

  US FDA approves new antibiotic for uncomplicated UTIs in nearly 30 years

  Health | March 26, 2025 8:03 IST

  UTIs are the most common type of infection that happens to women and are usually caused by bacteria including E. coli. The US FDA approved a new class of antibiotics that can help treat UTIs. Read on to know more.

• 

  FDA bans use of Red No. 3 from food, medicine citing cancer risks

  Health | January 17, 2025 11:56 IST

  The FDA is banning the use of Red No. 3, an artificial dye, due to its link to cancer. This comes after food safety advocacy groups filed a petition in 2022. Read on to know more.

• 

  US lawmakers question FDAs drug inspection programme in India and China amid drug shortage

  World | June 25, 2024 9:18 IST

  In a letter addressed to FDA Commissioner Robert Califf, lawmakers expressed on Monday that the disparity in inspection results seems to be yet another instance of institutional deficiencies and dysfunction within the FDA's overseas drug inspection program.

• 

  US approves first COVID-19 shots for infants and preschoolers

  World | June 17, 2022 19:04 IST

  The FDA also authorized Moderna’s vaccine for school-aged children and teens. Pfizer’s shots had previously been the only ones available for those ages.

• 

  Why is there a shortage of baby formula in the U.S. | Explained

  India | May 27, 2022 12:28 IST

  The problems began last year as the COVID-19 pandemic led to disruptions in labor, transportation and raw materials — economy-wide issues that didn’t spare the formula industry. Inventory was further squeezed by parents stockpiling during COVID-19 lockdowns.

• 

  Rapid antigen tests have reduced sensitivity against Omicron: US FDA

  World | December 29, 2021 14:33 IST

  The findings are based on a study conducted by the FDA in collaboration with the US National Institutes of Health.

• 

  Merck COVID pill effective, experts will review safety: FDA

  World | November 26, 2021 22:58 IST

  The FDA scientists said their review identified several potential risks, including possible toxicity and birth defects.

• 

  Zydus Cadila gets FDA's approval to market generic cancer drug in US

  World | November 20, 2021 15:54 IST

  The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.  

• 

  FDA authorizes first e-cigarette, cites benefit for smokers

  World | October 13, 2021 12:38 IST

  While the products can now be legally sold in the U.S., the FDA stressed they are neither safe nor “FDA approved,” and that people who don’t smoke shouldn’t use them.

• 

  Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

  World | October 12, 2021 20:19 IST

  The FDA meetings come as U.S. vaccinations have climbed back above 1 million per day on average.

• 

  US panel backs COVID-19 boosters only for seniors, high-risk

  World | September 18, 2021 6:47 IST

  An influential federal advisory panel overwhelmingly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.

Advertisement
• 

  Anthony Fauci hopeful of COVID vaccines getting full OK by FDA within weeks

  World | August 09, 2021 8:12 IST

  The FDA has only granted emergency-use approval of the Pfizer, Moderna and Johnson & Johnson vaccines, but the agency is expected to soon give full approval to Pfizer.

• 

  Some in US getting COVID-19 boosters without FDA approval

  World | August 08, 2021 7:16 IST

  Americans have managed to get COVID booster shots by taking advantage of the nation’s vaccine surplus and loose tracking of those who have been fully vaccinated.

• 

  FDA adds warning of rare reaction risk to J&J Covid vaccine

  World | July 13, 2021 7:43 IST

  US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem.

• 

  We respect US's decision: Centre on Covaxin EUA rejection

  India | June 11, 2021 19:18 IST

  Bharat Biotech's application for approval of indigenous COVID-19 vaccine, Covaxin, has been rejected by the US FDA that cited a lack of sufficient data.

• 

  FDA expected to OK Pfizer vaccine for teens within week

  World | May 04, 2021 10:14 IST

  FDA is expected to authorize Pfizer's COVID-19 vaccine for young adults age 12 and older by next week

• 

  Study identifies possible Covid drugs

  Science | April 03, 2021 14:55 IST

  A team of researchers has identified nine potential new Covid-19 treatments, including three, that were already approved by the US Food and Drug Administration (FDA) for treating other diseases.

• 

  US FDA Hahn commissioner refuses to offer COVID-19 vaccine timing

  World | July 06, 2020 8:00 IST

  Commissioner of the US Food and Drug Administration (FDA) Stephen Hahn has refused to offer a timeline for the COVID-19 vaccine, which US President Donald Trump suggested could be available "long before the end of the year".

• 

  US drug body FDA revokes Hydroxychloroquine status as emergency medicine to treat COVID-19

  World | June 15, 2020 23:33 IST

  The FDA said it was no longer reasonable to believe that oral formulations of hydroxychloroquine and the related drug chloroquine may be effective in treating the respiratory illness caused by the novel coronavirus.

• 

  FDA approves Dr Reddy's NDA for migraine drug

  Business | May 06, 2020 19:30 IST

  Dr Reddy's Laboratories Ltd said the companys NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been approved by the US Food and Drug Administration.